Skip to content

I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.

Allison J Matthews, Rachel Sutherland, Amy Peacock, Joe Van Buskirk, Elizabeth Whittaker, Lucinda Burns, Raimondo Bruno

International Journal of Drug Policy February 1, 2017 DOI: 10.1016/j.drugpo.2016.11.004 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional survey Peer reviewed
Sample size 1,208
Population Frequent psychostimulant consumers interviewed for the Australian Ecstasy and related Drugs Reporting System (EDRS)
Duration Last six months on the last occasion of use
Topics DMT LSD MDMA
Keywords Mephedrone New psychoactive substances Subjective ratings Newer substances Stimulant-type nps Newer hallucinogens Traditional drugs Subjective drug ratings Frequent psychostimulant consumers Subjectively rated Rated less favorably User interest User appeal Less appealing Stood out Pleasurable effects Negative experiences
Citations 23
Key findings Stimulant-type NPS were rated less favorably than ecstasy and cocaine, while DMT showed similar pleasurable effects to LSD with lower negative effects.

Abstract

Over the past decade, monitoring systems have identified the rapid emergence of new psychoactive substances (NPS). While the use of many NPS is minimal and transitory, little is known about which products have potential for capturing the attention of significant proportions of the drug consuming market. The aim of this study was to explore self-reported experiences of three commonly used NPS classes within the Australian context (synthetic cathinones, hallucinogenic phenethylamines and hallucinogenic tryptamines) relative to traditional illicit drug counterparts. Frequent psychostimulant consumers interviewed for the Australian Ecstasy and related Drugs Reporting System (EDRS) (n=1208) provided subjective ratings of the pleasurable and negative (acute and longer-term) effects of substances used in the last six months on the last occasion of use, and the likelihood of future use. Stimulant-type NPS (e.g., mephedrone, methylone) were rated less favourably than ecstasy and cocaine in terms of pleasurable effects and likelihood of future use. DMT (a hallucinogenic tryptamine) showed a similar profile to LSD in terms of pleasurable effects and the likelihood of future use, but negative effects (acute and comedown) were rated lower. Hallucinogenic phenethylamines (e.g., 2C-B) showed a similar negative profile to LSD, but were rated as less pleasurable and less likely to be used again. The potential for expanded use of stimulant-type NPS may be lower compared to commonly used stimulants such as ecstasy and cocaine. In contrast, the potential of DMT may be higher relative to LSD given the comparative absence of negative effects.

Comparable studies

Other cross-sectional and survey studies on DMT, most cited first.

Study Year Design Participants
Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT Adults reporting a single most memorable God encounter experience, either nondrug or... 2019 Cross-sectional survey n = 4,285
Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: Phenomenology, interpretation, and enduring effects. People who had a memorable entity encounter after taking N,N-dimethyltryptamine 2020 Survey n = 2,561
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. Adults who used 5-MeO-DMT in a group setting with structured procedures 2019 Cross-sectional survey n = 362
The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption. Adults who use 5-MeO-DMT, recruited via internet-based advertisements; predominantly... 2018 Cross-sectional survey n = 515
Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample People who completed the Global Drug Survey online in 2012, many of whom have used drugs 2013 Cross-sectional survey n = 22,289

Citations in the library

Cited by 8

and 3 more in the library

Cites 6

and 1 more in the library

Explore topics